JAMADerm Profile Banner
JAMA Dermatology Profile
JAMA Dermatology

@JAMADerm

Followers
29K
Following
186
Media
2K
Statuses
14K

JAMA Dermatology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

Chicago, IL
Joined July 2009
Don't wanna be here? Send us removal request.
@JAMADerm
JAMA Dermatology
1 day
The term scleroderma often is used to describe 2 separate autoimmune disorders: (1) morphea and (2) systemic sclerosis. This Patient Page describes the symptoms, diagnosis, and treatment of scleroderma.
Tweet media one
0
6
26
@JAMADerm
JAMA Dermatology
1 day
A woman in her 40s with a medical history of complex regional pain syndrome presented to the dermatology department for evaluation of a pruritic recurrent rash on her right anterior thigh that started 1 month prior. Take the Clinical Challenge:
Tweet media one
1
6
26
@JAMADerm
JAMA Dermatology
2 days
This case study demonstrates that abrocitinib, a selective JAK1 inhibitor, successfully treated a patient with SAPHO syndrome, showing improvement in symptoms and quality of life.
Tweet media one
0
4
27
@JAMADerm
JAMA Dermatology
3 days
A woman in her 40s presented to a immunobullous disease clinic with a 30-year history of an intensely pruritic eruption predominantly affecting her legs, forearms, and hands. What is your diagnosis?
Tweet media one
0
0
11
@JAMADerm
JAMA Dermatology
4 days
Sporotrichosis, a subcutaneous mycosis caused by Sporothrix species, has one of the highest human incidence rates in China globally. This case series reports the incidence of sporotrichosis among 6 restaurant workers in Shandong, China.
Tweet media one
1
4
32
@JAMADerm
JAMA Dermatology
4 days
Acne keloidalis nuchae (AKN) is a chronic skin condition characterized by inflamed hair follicles that can cause hair loss and substantial scarring. This Patient Page describes the symptoms, diagnosis, and treatment of AKN. @drprince.a
Tweet media one
1
19
105
@JAMADerm
JAMA Dermatology
5 days
Patients with autoimmune skin diseases experienced better survival outcomes after antineoplastic treatment for cancer.
Tweet media one
0
3
11
@JAMADerm
JAMA Dermatology
5 days
The combination of linperlisib and chidamide was a safe and potentially effective treatment for relapsed or refractory cutaneous T-cell lymphoma.
Tweet media one
0
0
5
@JAMADerm
JAMA Dermatology
5 days
In this network meta-analysis, sonelokimab, adalimumab, lutikizumab, and bimekizumab were the most effective treatments for moderate to severe hidradenitis suppurativa.
Tweet media one
0
1
17
@JAMADerm
JAMA Dermatology
7 days
Standard alphapapillomavirus vaccination was found to reduce actinic keratosis burden in immunocompetent individuals with multiple lesions. #AAD2025 .
Tweet media one
0
5
13
@JAMADerm
JAMA Dermatology
8 days
Most viewed this week from @JAMADerm: . Dupilumab treatment in atopic dermatitis patients is associated with a 58% higher risk of developing psoriasis compared to other systemic agents.
Tweet media one
0
4
22
@JAMADerm
JAMA Dermatology
8 days
In cutaneous squamous cell carcinoma (CSCC), the number of risk factors is directly associated with increased risks of recurrence, metastasis, and disease-related death.
0
3
12
@JAMADerm
JAMA Dermatology
8 days
Bimekizumab, an IL-17A and IL-17F inhibitor, improved severe, treatment-resistant acne conglobata in two patients, suggesting its potential as an effective treatment option.
2
12
40
@JAMADerm
JAMA Dermatology
8 days
This consensus statement established diagnostic criteria for metastatic cutaneous Crohn disease (MCD), which include major and minor clinical and histopathological criteria.
0
0
4
@JAMADerm
JAMA Dermatology
9 days
Photodynamic therapy exhibited good tolerability and safety in non-immunocompromised patients with localized cutaneous M marinum infections.
Tweet media one
0
3
28
@JAMADerm
JAMA Dermatology
9 days
A 6-year-old girl presented to an outpatient clinic with a history of a red plaque on her chest for over 4 years. What is your diagnosis?
Tweet media one
0
0
3
@JAMADerm
JAMA Dermatology
10 days
Most viewed this week from @JAMADerm: . Dupilumab treatment in atopic dermatitis patients is associated with a 58% higher risk of developing psoriasis compared to other systemic agents.
Tweet media one
0
4
28
@JAMADerm
JAMA Dermatology
11 days
A man in his late 60s was seen for a new onset of an erythematous eruption on his arms and upper trunk. Read the full case report:
0
1
4
@JAMADerm
JAMA Dermatology
11 days
Increased environmental pollutants and temperature extremes are associated with a higher burden of atopic dermatitis.
Tweet media one
0
3
14
@JAMADerm
JAMA Dermatology
12 days
VISIBLE trial Cohort B: Guselkumab effectively clears scalp psoriasis, improves quality of life, and maintains results through 48 weeks in individuals with diverse skin tones.
Tweet media one
0
0
7